126458-15-9 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-Methylpiperazine tartrate is used as an active pharmaceutical ingredient for the treatment of certain diseases and conditions. Its unique combination of (S)-2-methylpiperazine and tartrate provides therapeutic benefits in various medical applications.
(S)-2-Methylpiperazine tartrate is used as a building block in the synthesis of various pharmaceuticals due to its versatile chemical properties and potential for creating new drug molecules.
(S)-2-Methylpiperazine tartrate is used as a solvent and intermediate in organic synthesis, facilitating the production of other chemical compounds and pharmaceuticals.
(S)-2-Methylpiperazine tartrate is used as a chelating agent for metal ion control, helping to regulate the presence of metal ions in pharmaceutical formulations and ensuring their stability and efficacy.
(S)-2-Methylpiperazine tartrate is used as a buffering agent in pharmaceutical formulations to maintain a stable pH environment, which is crucial for the effectiveness and safety of the final product.
Check Digit Verification of cas no
The CAS Registry Mumber 126458-15-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,4,5 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 126458-15:
(8*1)+(7*2)+(6*6)+(5*4)+(4*5)+(3*8)+(2*1)+(1*5)=129
129 % 10 = 9
So 126458-15-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H12N2.2ClH/c1-5-4-6-2-3-7-5;;/h5-7H,2-4H2,1H3;2*1H/t5-;;/m0../s1
126458-15-9Relevant articles and documents
NOVEL PROCESS
-
Page 24-25, (2010/02/05)
The present invention relates to a process for the preparation of compounds which are therapeutically active in the central nervous system. In one aspect, the invention relates to a process for the preparation of compounds of the general formula (I). The invention also relates to (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine, hydrochloride and a process for preparing the same. Another object of the present invention is a compound of the formula (I). Another object of the present invention is a method for the treatment or prophylaxis of a serotonin-related disorder, comprising administering to a subject in need thereof an effective amount of the compound above; as well as the use of said compound to manufacture a medicament for the treatment of a serotonin-related disorder.